Article
Isomerization of antimalarial drug WR99210 explains its inactivity in a commercial stock
2020-07-01
Abstract excerpt
<h4>ABSTRACT</h4> WR99210, a former antimalarial drug candidate now widely used for the selection of Plasmodium transfectants, selectively targets the parasite dihydrofolate reductase thymidine synthase bifunctional enzyme (DHFR-TS) but not human DHFR, which is not fused with TS. Accordingly, WR99210 and plasmids expressing human dhfr have become valued tools for the genetic modification of parasites in the lab...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9860aebe-8f72-5578-8c01-5dc91d9e96e9
- DOI
- 10.1101/2020.07.01.182402
